Modeling Framework for Economic Evaluation of Disease-Modifying Therapies in Parkinson’s Disease: Evidence Review and Expert Opinion

Anshul Shah, Richard Dodel, Saifuddin Kharawala, Katharina Klapper, Matthew May, Per Odin, Angelica Asis, Gennaro Pagano, Anna Kotzeva, Camille Carroll

Open source

DOI: 10.1007/s40273-026-01669-2
Published: 2026-09-30
Container: PharmacoEconomics
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40273-026-01669-2,
  title = {Modeling Framework for Economic Evaluation of Disease-Modifying Therapies in Parkinson’s Disease: Evidence Review and Expert Opinion},
  author = {Anshul Shah and Richard Dodel and Saifuddin Kharawala and Katharina Klapper and Matthew May and Per Odin and Angelica Asis and Gennaro Pagano and Anna Kotzeva and Camille Carroll},
  year = {2026},
  journal = {PharmacoEconomics},
  doi = {10.1007/s40273-026-01669-2},
  url = {https://doi.org/10.1007/s40273-026-01669-2}
}

RIS

TY  - JOUR
TI  - Modeling Framework for Economic Evaluation of Disease-Modifying Therapies in Parkinson’s Disease: Evidence Review and Expert Opinion
AU  - Anshul Shah
AU  - Richard Dodel
AU  - Saifuddin Kharawala
AU  - Katharina Klapper
AU  - Matthew May
AU  - Per Odin
AU  - Angelica Asis
AU  - Gennaro Pagano
AU  - Anna Kotzeva
AU  - Camille Carroll
PY  - 2026
JO  - PharmacoEconomics
DO  - 10.1007/s40273-026-01669-2
UR  - https://doi.org/10.1007/s40273-026-01669-2
ER  -

APA

Shah, A., Dodel, R., Kharawala, S., Klapper, K., May, M., Odin, P., Asis, A., Pagano, G., Kotzeva, A., & Carroll, C. (2026). Modeling Framework for Economic Evaluation of Disease-Modifying Therapies in Parkinson’s Disease: Evidence Review and Expert Opinion. PharmacoEconomics. https://doi.org/10.1007/s40273-026-01669-2

Source records

crossref · retrieved 2026-11-04T11:32:29.980Z